E. Brandão

发表

A novel EGFR mutation in exon 18 with high sensitivity to EGFR TKI treatment with reduced dose.

M. Cruz, M. Pantarotto, E. Brandão, 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

EP02.04-005 Phase II NAUTIKA1 Study of Targeted Therapies in Stage II-III NSCLC: Preliminary Data of Neoadjuvant Alectinib for ALK+ NSCLC

J. Chaft, B. Sepesi, E. Toloza, 2022, Journal of Thoracic Oncology.

Safety and efficacy of modified dose-attenuated FOLFIRINOX chemotherapy in patients over 65 years with advanced pancreatic adenocarcinoma.

Marcos André Costa, M. Cruz, Carina Meira Abrahão, 2013 .